Health Condition 1: M199- Osteoarthritis, unspecified site
Conditions
Interventions
Intervention1: A PROSPECTIVE STUDY TO ASCERTAIN THE EFFECTIVENESS OF CONSTITUTIONAL HOMOEOPATHIC MEDICINES IN CASES OF OESTEOARTHRITIS IN AGE GROUP OF BETWEEN 35-65 YRS BY USING WESTERN ONTARIO McMAS
Sponsors
Sainath Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age: Patients aged 35-65 years with a diagnosis of osteoarthritis (OA) based on clinical and radiological findings. 2. OA Diagnosis: Patients with a confirmed diagnosis of OA from radiological findings. 3. OA Severity: Patients with mild to moderate OA, as defined by the Kellgren-Lawrence grading system or the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). 4. Homoeopathic Treatment: Patients willing to receive homoeopathic treatment as part of the study.
Exclusion criteria
Exclusion criteria: 1. Severe OA: Patients with severe OA, as defined by the Kellgren-Lawrence grading system or WOMAC. 2. Other Rheumatic Diseases: Patients with other rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, or gout. 3. Recent Injections or Surgery: Patients who have received corticosteroid injections or undergone surgery on the affected joint within the past 6 months. 4. Medications: Patients taking medications that may interfere with the study outcomes, such as: - Corticosteroids , Immunosuppressants , Opioids 5. Pregnancy or Lactation: Pregnant or lactating women. 6. Allergies or Sensitivities: Patients with known allergies or sensitivities to homoeopathic remedies. 7. Concurrent Treatment: Patients receiving concurrent treatment for OA, such as: - Acupuncture - Other alternative therapies 8. Cognitive or Psychiatric Impairment: Patients with significant cognitive or psychiatric impairment that may affect their ability to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) total score from baseline to follow-up. WOMAC measures pain, stiffness, and physical function internationally validated, widely used in OA research.Timepoint: Baseline 15 days , 30 days , 45 days post treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in WOMAC domain scores (pain, stiffness, function) at 4, 8, and 12 weeks. Change in analgesic/NSAID requirement. Safety and tolerability of homoeopathic medicines.Timepoint: WOMAC Domain Scores (Pain, Stiffness, Physical Function) Time points: Baseline, 4 weeks, 8 weeks, 12 weeks (primary endpoint), and optionally 24 weeks (if you want longer-term follow-up). Use of Concomitant Analgesics / NSAIDs (frequency and dose reduction compared to baseline) Time points: Recorded at each follow-up visit (4, 8, 12 weeks). Adverse Events and Tolerability Time points: Monitored continuously; documented at every visit (4, 8, 12 weeks). Quality of Life (optional, e.g., SF-36 or EQ-5D if you plan to include it) Time points: Baseline and 12 weeks | — |
Countries
India
Contacts
Public ContactKanani Manas Bhavikkumar
Rajkot Homoeopathic Medical College
Outcome results
None listed